QR Code

Nanoliposomal VEGF-R2 peptide vaccine acts as an effective therapeutic vaccine in a murine B16F10 model of melanoma

Abstract Background The vascular endothelial growth factor receptor-2 (VEGFR-2) plays an important role in melanoma development and progression. Peptide vaccines have shown great potential in cancer immunotherapy by targeting VEGFR-2 as a tumor-associated antigen and boosting the immune response aga...

Full description

Saved in:
Main Authors: Fatemeh Zahedipour, Parvin Zamani, Mohammad Mashreghi, Mojgan Astaneh, Mojtaba Sankian, Atefeh Amiri, Khadijeh Jamialahmadi, Mahmoud Reza Jaafari
Format: Artigo
Language:Inglês
Published: BMC 2023-06-01
Series:Cancer Nanotechnology
Subjects:
Nanoliposomal vaccine
VEGFR-2
Peptide vaccine
Melanoma
Online Access:https://doi.org/10.1186/s12645-023-00213-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items